Latest From Biotech Now

2013 Biotechnology Holiday Gift Ideas

xmas-presents

Welcome to this year’s BIOtechNOW Gift Guide – our most loved biotechnology gift ideas from 2013 and beyond. Here you’ll find gifts that promote women in the sciences, interesting biotech books, and, of course, a few gifts inspired by some of our very first biotech inventions! So whether you’re looking for a last-minute gift idea or a way to blow part of that holiday bonus consider this your guide to yuletide biotech bliss! Add your Read More >

Corporate  |  Leave a comment  |  Email This Post
Tags: , , , ,

Moms Urged to Subscribe to the ‘Precautionary Principle’ on GMOs

GMO Answers

“Rather than falling for these tactics, women should take a reasoned look at the facts behind biotechnology and the cost and consequences of the policies activists advance.” – Julie Gunlock BIO wanted to bring attention to a wonderful piece in the National Review Online, titled Biotech’s Mommy Issue: Women are targeted by anti-GMO activists but deserve to know the truth. Julie Gunlock notably blogs on how advertisers and marketing experts push the anti-GMO agenda by Read More >

Farmer Gene  |  1 Comment  |  Email This Post
Tags: , , ,

BIO 2013 Pacific Rim Summit Ends with a Look at Natural Gas

Pac_Rim115x75

This year marked the first time in the event’s eight year history that it was held in California. With 400 attendees present, BIO’s 2013 Pacific Rim Summit had a record number of exhibitors, poster presenters, and media present. BIO concluded its summit with a robust plenary titled, The Golden Age of Gas, moderated by Jonathan Burbaum, Program Director at ARPA-E, panelists consisted of the Laurel Harmon, VP of Government Relations, Lanzatech, Alan Shaw, Chairman of the Board, Read More >

Environmental & Industrial  |  Leave a comment  |  Email This Post
Tags: , , , , ,

What’s Behind the Biotech IPO Boom?

BIOtech-stocks

Everyone knows that it’s been a knock-out year for the biotech sector in the public markets, which includes a large and well-performing IPO class. So far in 2013, 39 US-based companies have gone public, five European-based companies, and one Canadian company. Of these 45 IPOs, 42 companies have gone public on US stock exchanges. That’s over double the amount we saw in 2012. This year’s IPOs have also been successful at raising the amount of money Read More >

Business and Investments, Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Fewer Small Public Biotechs Today

Fig2-size-2008-vs-2013-115x76

A lot can happen in six years. The number of active biotech companies currently trading on US exchanges is now only 300. At the start of 2008, there were almost 400 active companies.   The net decrease in the number of active companies since 2008 is 24%. Had it not been for all the IPO activity we have seen this year, the decrease would have been substantially more. In fact, only 55% of the original Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,